TABLE 2.
Plasma lipid, lipoprotein, and apolipoprotein concentrations in CKD and control subjects
| Lipid, Lipoprotein, Apolipoprotein | CKD (n = 10) | Controls (n = 20) | P |
|---|---|---|---|
| Total cholesterol (mg/dl) | 218 (86) | 203 (70) | 0.18 |
| LDL cholesterol (mg/dl) | 133 (66) | 117 (43) | 0.91 |
| Triglycerides (mg/dl) | 124 (142) | 71 (53) | 0.004 |
| HDL cholesterol (mg/dl) | 59 (35) | 59 (35) | 0.95 |
| apoB (mg/dl) | 120 (40) | 92 (30) | 0.035 |
| apoA-I (mg/dl) | 160 (70) | 160 (50) | 0.62 |
| apoA-II (mg/dl) | 30 (7) | 30 (10) | 0.65 |
| apoC-II (mg/l) | 34.2 (26.7) | 32.4 (13.0) | 0. 71 |
| apoC-III (mg/l) | 200 (74) | 98 (34) | <0.0001 |
| apoC-II/C-III ratio | 0.21 (0.12) | 0.32 (0.2) | 0.001 |
| apoB-48 (mg/l) | 4.5 (2.2) | 2.2 (2.6) | <0.0001 |
| apoE (mg/l) | 62.2 (51.5) | 43.6 (52.8) | 0.21 |
| Lipoprotein lipase mass (ng/ml) | 51.0 (31.6) | 42.7 (41.0) | 0.81 |
Data are presented as median (IQR). To convert cholesterol, HDL-cholesterol. and LDL-cholesterol in mg/dl to mmol/L, multiply by 0.02586; triglycerides in mg/dl to mmol/L, multiply by 0.01129; apoC-III in mg/dl to mg/L, multiply by 10.